NCT00877006 · Interventional trial
Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study
Overall registry status Completed
Phase 3
Conditions Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma
Delaware Valley sites
- Teva Investigational Site 3 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory